{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:16:38Z","timestamp":1789398998182,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The level of neuromuscular blockade can be assessed by subjective (qualitative) and objective (quantitative) methods. This study aims to compare the dosage of the neuromuscular blocking agents (NMBA) rocuronium and the need for reversion by sugammadex between those methods. A retrospective, observational analysis was conducted. In the tactile qualitative-neuromuscular monitoring-group (tactile NMM) (n\u2009=\u2009244), muscle contractions were assessed tactilely. In the quantitative neuromuscular monitoring-group (n\u2009=\u2009295), contractions were accessed using an acceleromyograph. Primary endpoints were dosage of rocuronium per minute operation-time (milligram per kilogram bodyweight per minute (mg\/kgBW\/min)), count of repeated rocuronium administrations and use of sugammadex. Secondary endpoints were: NMM use before repeated NMBA application or extubation, time to extubation, post-operative oxygen demand. A total of n\u2009=\u2009539 patients were included. n\u2009=\u2009244 patients were examined with tactile NMM and 295 patients by quantitative NMM. Quantitative NMM use resulted in significantly lower rocuronium dosing (tactile NMM: 0.01 (\u00b1\u20090.007) mg\/kgBW\/min vs. quantitative NMM: 0.008 (\u00b1\u20090.006) mg\/kgBW\/min (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001)). In quantitative NMM use fewer repetitions of rocuronium application were necessary (tactile NMM: 83% (n\u2009=\u2009202) vs. quantitative NMM: 71% (n\u2009=\u2009208) <jats:italic>p<\/jats:italic>\u2009=\u20090.007). Overall, 24% (n\u2009=\u200958) in the tactile NMM-group, and 20% (n\u2009=\u200960) in the quantitative NMM-group received sugammadex ((<jats:italic>p<\/jats:italic>\u2009=\u20090.3), OR: 1.21 (0.81\u20131.82)). Significantly fewer patients in the quantitative NMM-group required oxygen-supply postoperative (quantitative NMM: 43% (n\u2009=\u2009120)) vs. tactile NMM: 57% (n\u2009=\u2009128)) (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). The use of quantitative assessment of NMBA results in a lower overall dosage and requires fewer repetitions of rocuronium application. Therefore, quantitative monitoring systems should be used to monitor NMBA intraoperatively to reduce NMBA dosing, while achieving continuous neuromuscular blockade.\n<\/jats:p>","DOI":"10.1007\/s10877-022-00909-y","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T02:02:27Z","timestamp":1660960947000},"page":"509-516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of quantitative versus qualitative neuromuscular blockade monitoring on rocuronium consumption in patients undergoing abdominal and gynecological surgery: a retrospective cohort study"],"prefix":"10.1007","volume":"37","author":[{"given":"Lea Valeska","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Steeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Iken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6sta","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Piekarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-9585","authenticated-orcid":false,"given":"Florian J\u00fcrgen","family":"Raimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,20]]},"reference":[{"issue":"6","key":"909_CR1","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/00000542-200012000-00008","volume":"93","author":"M King","year":"2000","unstructured":"King M, et al. Requirements for muscle relaxants during radical retropubic prostatectomy. Anesthesiology. 2000;93(6):1392\u20137.","journal-title":"Anesthesiology"},{"issue":"9","key":"909_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/anae.14304","volume":"73","author":"BW Koo","year":"2018","unstructured":"Koo BW, et al. Effects of depth of neuromuscular block on surgical conditions during laparoscopic colorectal surgery: a randomised controlled trial. Anaesthesia. 2018;73(9):1090\u20136.","journal-title":"Anaesthesia"},{"issue":"3","key":"909_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/bja\/aet377","volume":"112","author":"CH Martini","year":"2014","unstructured":"Martini CH, et al. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate versus deep neuromuscular block. Br J Anaesth. 2014;112(3):498\u2013505.","journal-title":"Br J Anaesth"},{"issue":"2","key":"909_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.bja.2020.09.024","volume":"126","author":"GHM Honing","year":"2021","unstructured":"Honing GHM, et al. Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery. Br J Anaesth. 2021;126(2):377\u201385.","journal-title":"Br J Anaesth"},{"issue":"9","key":"909_CR5","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1399-6576.1997.tb04851.x","volume":"41","author":"H Berg","year":"1997","unstructured":"Berg H, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand. 1997;41(9):1095\u2013103.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"12","key":"909_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/EJA.0b013e328345cd11","volume":"28","author":"M Sauer","year":"2011","unstructured":"Sauer M, et al. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol. 2011;28(12):842\u20138.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"909_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13741-021-00183-7","volume":"10","author":"FK Alenezi","year":"2021","unstructured":"Alenezi FK, et al. The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study. Perioper Med (Lond). 2021;10(1):14.","journal-title":"Perioper Med (Lond)"},{"issue":"1","key":"909_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bja.2019.08.023","volume":"124","author":"M Blobner","year":"2020","unstructured":"Blobner M, et al. Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data. Br J Anaesth. 2020;124(1):63\u201372.","journal-title":"Br J Anaesth"},{"issue":"1","key":"909_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","volume":"107","author":"GS Murphy","year":"2008","unstructured":"Murphy GS, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130\u20137.","journal-title":"Anesth Analg"},{"issue":"7","key":"909_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1399-6576.2007.01352.x","volume":"51","author":"T Fuchs-Buder","year":"2007","unstructured":"Fuchs-Buder T, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51(7):789\u2013808.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"909_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1213\/ANE.0000000000002387","volume":"126","author":"GS Murphy","year":"2018","unstructured":"Murphy GS. Neuromuscular monitoring in the perioperative period. Anesth Analg. 2018;126(2):464\u20138.","journal-title":"Anesth Analg"},{"issue":"4","key":"909_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00000542-198510000-00015","volume":"63","author":"J Viby-Mogensen","year":"1985","unstructured":"Viby-Mogensen J, et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology. 1985;63(4):440\u20133.","journal-title":"Anesthesiology"},{"issue":"3","key":"909_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/bja\/ael386","volume":"98","author":"M Naguib","year":"2007","unstructured":"Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98(3):302\u201316.","journal-title":"Br J Anaesth"},{"issue":"4","key":"909_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00000542-197810000-00003","volume":"49","author":"WD Owens","year":"1978","unstructured":"Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications: a study of consistency of ratings. Anesthesiology. 1978;49(4):239\u201343.","journal-title":"Anesthesiology"},{"issue":"6","key":"909_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1399-6576.1995.tb04173.x","volume":"39","author":"CR Mortensen","year":"1995","unstructured":"Mortensen CR, et al. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium. Acta Anaesthesiol Scand. 1995;39(6):797\u2013801.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"909_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/bja\/aex116","volume":"118","author":"MH Bruintjes","year":"2017","unstructured":"Bruintjes MH, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth. 2017;118(6):834\u201342.","journal-title":"Br J Anaesth"},{"issue":"9","key":"909_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12630-019-01373-0","volume":"66","author":"DP Veelo","year":"2019","unstructured":"Veelo DP, et al. On-demand versus continuous rocuronium infusion for deep neuromuscular relaxation in patients undergoing thoraco-laparoscopic esophagectomy: a randomized-controlled clinical trial (DEPTH). Can J Anesth J canadien d\u2019anesth\u00e9sie. 2019;66(9):1062\u201374.","journal-title":"Can J Anesth J canadien d'anesth\u00e9sie"},{"issue":"3","key":"909_CR18","first-page":"389","volume":"109","author":"GS Murphy","year":"2008","unstructured":"Murphy GS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual meeting abstracts and adverse respiratory events in the postanesthesia care unit. Anesthesiol J Am Soc Anesthesiol. 2008;109(3):389\u201398.","journal-title":"Anesthesiol J Am Soc Anesthesiol"},{"issue":"2","key":"909_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","volume":"117","author":"Y Kotake","year":"2013","unstructured":"Kotake Y, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117(2):345\u201351.","journal-title":"Anesth Analg"},{"issue":"2","key":"909_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(18)30294-7","volume":"7","author":"E Kirmeier","year":"2019","unstructured":"Kirmeier E, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. Lancet Respir Med. 2019;7(2):129\u201340.","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-022-00909-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-022-00909-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-022-00909-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:55:44Z","timestamp":1693518944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-022-00909-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s10877-022-00909-y","relation":{},"ISSN":["1387-1307","1573-2614"],"issn-type":[{"value":"1387-1307","type":"print"},{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,20]]},"assertion":[{"value":"26 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KZ: The Department of Anaesthesiology, Intensive Care Medicine & Pain Therapy of the University Hospital Frankfurt received support from B. Braun Melsungen, CSL Behring, Fresenius Kabi, and Vifor Pharma for the implementation of Frankfurt \u2018s Patient Blood Management program and KZ received honoraria for scientific lectures from CSL Behring, implatcast GmbH, med Update GmbH, Pharmacosmos and Vifor Pharma. FP received honoria from Pharmacosmos for scientific lectures. FJR received research funding from Boehringer Ingelheim, funding and travel expenses from HemoSonicsLLC and lecture fees from Keller Medical GmbH. All other Authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the ethics committee of the University Hospital Frankfurt (Date: 12. Jan. 2021 No. 20-1065).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/Consent to publish"}}]}}